🇺🇸 Cholestyramine Powder in United States

FDA authorised Cholestyramine Powder on 19 October 2021

Marketing authorisations

FDA — authorised 19 October 2021

  • Application: ANDA211856
  • Marketing authorisation holder: ALKEM LABS LTD
  • Status: approved

FDA

  • Application: ANDA073403
  • Marketing authorisation holder: APOTHECON
  • Local brand name: QUESTRAN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Other Cardiovascular approved in United States

Frequently asked questions

Is Cholestyramine Powder approved in United States?

Yes. FDA authorised it on 19 October 2021; FDA has authorised it.

Who is the marketing authorisation holder for Cholestyramine Powder in United States?

ALKEM LABS LTD holds the US marketing authorisation.